
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis
Chanitra Thuwajit, Peti Thuwajit, Pranisa Jamjantra, et al.
Oncology Letters (2017) Vol. 14, Iss. 1, pp. 623-634
Open Access | Times Cited: 25
Chanitra Thuwajit, Peti Thuwajit, Pranisa Jamjantra, et al.
Oncology Letters (2017) Vol. 14, Iss. 1, pp. 623-634
Open Access | Times Cited: 25
Showing 25 citing articles:
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1722
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1722
Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression
Laura González‐González, Javier Alonso
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 252
Laura González‐González, Javier Alonso
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 252
Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases
Anita K. Bakrania, Narottam Joshi, Xun Zhao, et al.
Pharmacological Research (2023) Vol. 189, pp. 106706-106706
Open Access | Times Cited: 40
Anita K. Bakrania, Narottam Joshi, Xun Zhao, et al.
Pharmacological Research (2023) Vol. 189, pp. 106706-106706
Open Access | Times Cited: 40
Extracellular matrix drives tumor organoids toward desmoplastic matrix deposition and mesenchymal transition
Gilles van Tienderen, Oskar Rosmark, Ruby Lieshout, et al.
Acta Biomaterialia (2022) Vol. 158, pp. 115-131
Closed Access | Times Cited: 34
Gilles van Tienderen, Oskar Rosmark, Ruby Lieshout, et al.
Acta Biomaterialia (2022) Vol. 158, pp. 115-131
Closed Access | Times Cited: 34
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro
Advances in cancer research (2020), pp. 321-387
Open Access | Times Cited: 36
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro
Advances in cancer research (2020), pp. 321-387
Open Access | Times Cited: 36
Periostin in chronic liver diseases: Current research and future perspectives
Yan Jia, Fenmiao Zhong, Shuoyi Jiang, et al.
Life Sciences (2019) Vol. 226, pp. 91-97
Closed Access | Times Cited: 30
Yan Jia, Fenmiao Zhong, Shuoyi Jiang, et al.
Life Sciences (2019) Vol. 226, pp. 91-97
Closed Access | Times Cited: 30
Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT‐dependent pathway in colorectal cancer cell migration
Suyanee Thongchot, Ekapot Singsuksawat, Nuttavut Sumransub, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 21, pp. 12421-12432
Open Access | Times Cited: 29
Suyanee Thongchot, Ekapot Singsuksawat, Nuttavut Sumransub, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 21, pp. 12421-12432
Open Access | Times Cited: 29
Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular Classifications
Sang Hoon Lee, Si Young Song
Cancers (2024) Vol. 16, Iss. 9, pp. 1761-1761
Open Access | Times Cited: 3
Sang Hoon Lee, Si Young Song
Cancers (2024) Vol. 16, Iss. 9, pp. 1761-1761
Open Access | Times Cited: 3
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Matricellular proteins in intrahepatic cholangiocarcinoma
Alphonse E. Sirica
Advances in cancer research (2022), pp. 249-281
Closed Access | Times Cited: 13
Alphonse E. Sirica
Advances in cancer research (2022), pp. 249-281
Closed Access | Times Cited: 13
Prognostic value of periostin in multiple solid cancers: A systematic review with meta‐analysis
Tao Yang, Zhengdong Deng, Zhongya Pan, et al.
Journal of Cellular Physiology (2019) Vol. 235, Iss. 3, pp. 2800-2808
Closed Access | Times Cited: 20
Tao Yang, Zhengdong Deng, Zhongya Pan, et al.
Journal of Cellular Physiology (2019) Vol. 235, Iss. 3, pp. 2800-2808
Closed Access | Times Cited: 20
Pathological Roles and Clinical Usefulness of Periostin in Type 2 Inflammation and Pulmonary Fibrosis
Junya Ono, Masayuki Takai, Ayami Kamei, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1084-1084
Open Access | Times Cited: 17
Junya Ono, Masayuki Takai, Ayami Kamei, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1084-1084
Open Access | Times Cited: 17
Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma
Silvia Affò, Laura Sererols-Viñas, Gemma Garcia‐Vicién, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 2
Silvia Affò, Laura Sererols-Viñas, Gemma Garcia‐Vicién, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 2
The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets
Naoyoshi Maeda, Katsumi Maenaka
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 10, pp. 2198-2198
Open Access | Times Cited: 15
Naoyoshi Maeda, Katsumi Maenaka
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 10, pp. 2198-2198
Open Access | Times Cited: 15
Overexpression of periostin and distinct mesothelin forms predict malignant progression in a rat cholangiocarcinoma model
Miguel Á. Manzanares, Deanna J. Campbell, Gabrielle T. Maldonado, et al.
Hepatology Communications (2017) Vol. 2, Iss. 2, pp. 155-172
Open Access | Times Cited: 14
Miguel Á. Manzanares, Deanna J. Campbell, Gabrielle T. Maldonado, et al.
Hepatology Communications (2017) Vol. 2, Iss. 2, pp. 155-172
Open Access | Times Cited: 14
Prognostic biomarkers for cholangiocarcinoma and their clinical implications
Charupong Saengboonmee, Kanlayanee Sawanyawisuth, Yaovalux Chamgramol, et al.
Expert Review of Anticancer Therapy (2018) Vol. 18, Iss. 6, pp. 579-592
Closed Access | Times Cited: 14
Charupong Saengboonmee, Kanlayanee Sawanyawisuth, Yaovalux Chamgramol, et al.
Expert Review of Anticancer Therapy (2018) Vol. 18, Iss. 6, pp. 579-592
Closed Access | Times Cited: 14
Research status and the prospect of POSTN in various tumors
Yue Yu, Changming Tan, Yuanyuan Jia
Neoplasma (2021) Vol. 68, Iss. 04, pp. 673-682
Open Access | Times Cited: 11
Yue Yu, Changming Tan, Yuanyuan Jia
Neoplasma (2021) Vol. 68, Iss. 04, pp. 673-682
Open Access | Times Cited: 11
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer
Carlo Cattrini, Paola Barboro, A. Rubagotti, et al.
Translational Oncology (2020) Vol. 13, Iss. 7, pp. 100789-100789
Open Access | Times Cited: 11
Carlo Cattrini, Paola Barboro, A. Rubagotti, et al.
Translational Oncology (2020) Vol. 13, Iss. 7, pp. 100789-100789
Open Access | Times Cited: 11
Development of an Engineered Peptide Antagonist against Periostin to Overcome Doxorubicin Resistance in Breast Cancer
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Faculty Opinions recommendation of Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Mitesh J. Borad
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature (2020)
Open Access
Mitesh J. Borad
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature (2020)
Open Access
Publications from Juntendo University Graduate School of Medicine, 2017 [5/6]
Tominaga Si
Juntendo Medical Journal (2020) Vol. 66, Iss. 1, pp. 63-92
Open Access
Tominaga Si
Juntendo Medical Journal (2020) Vol. 66, Iss. 1, pp. 63-92
Open Access
Development of an Engineered Peptide Antagonist against Periostin to Overcome Doxorubicin Resistance in Breast Cancer
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
Research Square (Research Square) (2020)
Open Access
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
Research Square (Research Square) (2020)
Open Access
Development of an Engineered Peptide Antagonist against Periostin to Overcome Doxorubicin Resistance in Breast Cancer
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
Research Square (Research Square) (2020)
Open Access
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
Research Square (Research Square) (2020)
Open Access
Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology
Lea Duwe, Laura Fouassier, Juan Lafuente‐Barquero, et al.
Translational Oncology (2022) Vol. 26, pp. 101531-101531
Open Access
Lea Duwe, Laura Fouassier, Juan Lafuente‐Barquero, et al.
Translational Oncology (2022) Vol. 26, pp. 101531-101531
Open Access
Development of an Engineered Peptide Antagonist against Periostin to Overcome Doxorubicin Resistance in Breast Cancer
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
Research Square (Research Square) (2021)
Open Access
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
Research Square (Research Square) (2021)
Open Access